Fundraising Fox

BioFluidica

Chapel Hill, US · Founded 2013 · North Carolina corporation

Founders & leadership

BioFluidica was founded in 2013 by Steven Soper.

SSSteven Soper
Steven SoperFounder
RM
Rolf MullerChief Executive Officer

Board

ST
Sam TetlowBoard director
MS
Michael StocumBoard director

Reported raises · per SEC filings

Form D private placements

$18.7M disclosed across 5 rounds · 2016–2021

▶$3.5MraisedDec 2021 · 12 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • ROLF MULLERExecutive Officer, Director
  • JUDY MULLER-COHNExecutive Officer
  • STEVEN SOPERExecutive Officer, Director
  • MICHAEL STOCUMDirector
  • PHILIP BUCHANANDirector
Offering amount
$10M
Amount sold
$3.5M
First sale
Nov 2021
Incorporated
Corporation, North Carolina
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedMar 2021 · 22 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sam C. TetlowExecutive Officer, Director
  • Rolf MullerExecutive Officer, Director
  • Michael StocumDirector
  • Steven SoperExecutive Officer, Director
  • Judy Muller-CohnExecutive Officer
  • Philip D. BuchananDirector
Offering amount
$8.2M
Amount sold
$6M
First sale
Nov 2019
Incorporated
Corporation, North Carolina
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedNov 2019 · 18 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rolf MullerExecutive Officer, Director
  • Sam TetlowExecutive Officer, Director
  • Michael StocumDirector
  • Steven SoperDirector
  • Philip D. BuchananDirector
Offering amount
$3M
Amount sold
$3M
First sale
Aug 2018
Incorporated
Corporation, North Carolina
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.1MraisedJul 2017 · 9 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Philip D. BuchananDirector
  • Michael StocumDirector
  • Steven SoperDirector
  • Sam TetlowExecutive Officer, Director
  • Rolf MullerExecutive Officer, Director
Offering amount
$5M
Amount sold
$4.1M
First sale
Jul 2017
Incorporated
Corporation, North Carolina, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedJun 2016 · 10 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rolf MullerExecutive Officer, Director
  • Michael StocumDirector
  • Steven SoperDirector
  • Sam TetlowDirector
Offering amount
$2M
Amount sold
$2M
First sale
Apr 2016
Incorporated
Corporation, North Carolina, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Labcorp7 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.

Companies competing with BioFluidica for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 10 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$1.4M
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$291.5K
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$348.8K
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$286.5K
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$239.1K
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase II2015$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase I2015$399.7K
National Institutes of Health (NIH)National Institutes of HealthPhase II2013$999.9K
National Institutes of Health (NIH)National Institutes of HealthPhase I2010$199.5K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who founded BioFluidica?
BioFluidica was founded by Steven Soper in 2013.
How much funding has BioFluidica raised?
BioFluidica has disclosed $18.7M raised across 5 rounds.
Where is BioFluidica headquartered?
BioFluidica is headquartered in Chapel Hill, US.